Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Gross margin
Koninklijke Philips N.V.'s gross margin over the twelve months to 30 September 2026 was 46.4%, up 1.2 percentage points from fiscal 2025 (45.2%). Over the past ten years it has ranged from 40.4% (fiscal 2022) to 47.2% (fiscal 2018); the current reading is higher than 73% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 45.2% | 2.05 |
| FY2024 | 43.1% | 2.14 |
| FY2023 | 41.0% | 0.64 |
| FY2022 | 40.4% | (1.43) |
| FY2021 | 41.8% | (3.17) |
| FY2020 | 45.0% | (0.60) |
| FY2019 | 45.6% | (1.65) |
| FY2018 | 47.2% | 1.19 |
| FY2017 | 46.0% | 2.72 |
| FY2016 | 43.3% | 2.64 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 46.4% | (2.87) |
| Jun 2026 | 49.3% | 4.11 |
| Mar 2026 | 45.2% | 0.29 |
| Dec 2025 | 44.9% | 0.51 |
| 37 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| EW Edwards Lifesciences Corporation compare | 78.0% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.7% |
| BSX Boston Scientific Corporation compare | 69.1% |
| DXCM DexCom, Inc. compare | 63.4% |
| PHG Koninklijke Philips N.V. | 46.4% |
| STE STERIS plc compare | 44.6% |
| GEHC GE HealthCare Technologies Inc. compare | 40.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement